Related Experiment Videos
APLG-Net: an anatomy-guided local-global hybrid network with progression-aware supervision for structural MRI-based
Bin Shi1,2, Zhimin Wang2, Jing Lian3
1School of Information Science and Engineering, Lanzhou University, Lanzhou, Gansu, China.
Frontiers in Neurology
|July 30, 2026
Summary
APLG-Net improves Alzheimer's disease (AD) classification using structural MRI by integrating local and global brain information. This anatomy-guided approach enhances the detection of mild cognitive impairment (MCI), a key early stage.
Area of Science:
- Neuroimaging
- Artificial Intelligence in Medicine
- Biomedical Engineering
Background:
- Structural MRI-based classification of Alzheimer's disease (AD) is challenging due to subtle anatomical differences and the difficulty in distinguishing mild cognitive impairment (MCI).
- Accurate classification is crucial for timely intervention and disease management.
Purpose of the Study:
- To develop an advanced deep learning model, APLG-Net, for improved classification of Normal Control (NC), MCI, and AD using structural MRI.
- To enhance the model's ability to capture both global and local brain structural information and incorporate disease progression patterns.
Main Methods:
- Proposed APLG-Net, a hybrid network combining a global whole-brain encoder and a local region-of-interest (ROI)-based encoder.
- Implemented cross-attention fusion and vector-gated integration for feature combination.
- Introduced an ordinal supervision strategy to model disease progression for enhanced classification.
Main Results:
- APLG-Net achieved 87.1% accuracy, 86.4% balanced accuracy, and 86.8% Macro-F1 on the ADNI dataset.
- Specifically, it reached an 85.6% F1 score for MCI classification.
- Outperformed existing CNN-based, Transformer-based, and other hybrid baseline models.
Conclusions:
- The integration of anatomical priors, local-global feature interaction, and ordinal supervision significantly boosts classification performance.
- APLG-Net demonstrates superior robustness and improved discrimination for MCI, a critical stage in Alzheimer's disease progression.